Frequently Asked Questions

What is CTE?

Chronic traumatic encephalopathy (CTE) is a progressive degenerative disease of the brain found in people with a history of repetitive head impacts (RHI) often incurred during contact sport play, military service, employment as a first responder, and other activities that involve repeated blows to the head. These may include symptomatic concussions as well as nonconcussive hits that do not cause symptoms. Nonconcussive hits are routine in many sports, including checking in ice hockey and heading the ball in soccer. CTE has been known to affect boxers since the 1920’s (when it was initially termed punch drunk syndrome or dementia pugilistica).  

In recent years, reports have been published of neuropathologically confirmed CTE found in other athletes, including football and hockey players (playing and retired), as well as in military veterans who have a history of repetitive brain trauma. CTE is not limited to current professional athletes; it has also been found in athletes who did not play sports after high school or college.  

The repeated brain trauma triggers progressive degeneration of the brain tissue, including the build-up of an abnormal protein called tau in a unique pattern. The pattern of tau seen in the brains of those with CTE is distinct from other neurodegenerative diseases such as Alzheimer’s disease (AD), progressive supra nuclear palsy (PSP), and corticobasal degeneration (CBD). These changes in the brain can begin months, years, or even decades after the last brain trauma or end of active athletic or military involvement.  

In both sets of photographs below, the brain tissue has been immunostained for tau protein, which appears as a dark brown color. 

Tau immunostained sections of the medial temporal lobe from 3 individuals: 

Whole brain section from a 65 year old control subject showing no tau protein deposition.
Whole brain section from John Grimsley showing abundant tau protein deposition in the amygdala and adjacent temporal cortex.
Whole brain section from a 73 year old world champion boxer with severe dementia showing very severe tau protein deposition in the amygdala and thalamus.

 

 

 

 

 

 

 

 

Microscopic section from 65 year old control subject showing no tau protein deposition.
Microscopic section from John Grimsley showing numerous tau positive neurofibrillary tangles and neurites in the amygdala.
Microscopic section from a 73 year old world champion boxer with severe dementia showing very severe tau protein deposition in the amygdala and thalamus.

 

 

 

 

 

 

 

What is TES? 

Chronic traumatic encephalopathy (CTE) is a neuropathological diagnosis and traumatic encephalopathy syndrome (TES) is the proposed clinical syndrome of CTE. 

To meet the 2021 TES criteria requires:  

  1. Substantial exposure to repetitive head impacts (RHI)
  2. Presence of at least one core clinical feature: cognitive impairment (in memory or executive function) or neurobehavioral dysregulation
  3. There is a progressive course
  4. The core clinical feature(s) are not fully accounted for by other disorders

If TES criteria are met, level of certainty of underlying CTE neuropathology (no, suggestive, possible, probable) can be determined based on the extent of exposure to RHI, and the presence of certain core and supportive clinical features, as well as dementia status. At this time, the TES criteria are for research purposes only and should not be used in the clinic.